CPMG Inc 13D and 13G filings for Reata Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-09-28 4:30 pm Sale | 2023-09-26 | 13D | Reata Pharmaceuticals, Inc. RETA | CPMG Inc | 0 0.000% | -5,020,431 (Position Closed) | Filing |
| 2023-08-01 5:17 pm Sale | 2023-07-28 | 13D | Reata Pharmaceuticals, Inc. RETA | CPMG Inc | 5,020,431 14.300% | -9,625 (-0.19%) | Filing |
| 2020-12-29 5:31 pm Purchase | 2020-12-23 | 13D | Reata Pharmaceuticals, Inc. RETA | CPMG Inc | 5,030,056 15.200% | 1,269 (+0.03%) | Filing |